•  
  •  
  •  
  •  

2025-09-30 18:15:14

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Umiya Mobile Limited Strengthens Market Presence with 36 New Stores Post IPO
  • Avantel Ltd to inaugurate new facility on Oct 2, 2025
  • Solarium Green Energy Ltd receives orders worth Rs. 18.77 crores
  • Capricorn Systems Global Solutions Ltd receives order for supply of broken rice
  • Anand Rayons Ltd receives approval for STAPII trademark

Keywords Selected:  IOC

Research

  • Biocon Limited - Generics & research grow; biosimilar stagnates - ICICI Securities
  • Q4FY22 Result Update – Biocon Ltd - ICICI Direct
  • Biocon - Q4FY22 First Cut - ICICI Direct
  • Q3FY22 Result Update - Biocon Ltd - ICICI Direct
  • Q2FY22 Result Update - Biocon Ltd - ICICI Direct

Stock Report

  • The Shipping Corporation of India Ltd signs MoU with BPCL, HPCL and IOCL
  • Qualitek Labs Limited receives order from Indian Oil Corporation Ltd
  • Biocon Inaugurates First U.S. Manufacturing Facility in Cranbury, New Jersey
  • U.S. FDA Completes Inspection at Biocon Biologics' Facility at Biocon Campus, Bengaluru, India
  • Solapur Bioenergy Systems Ltd begins generation and dispatch of Compressed Biogas from IOCL Gorakhpur CBG Plant
  • Cohance Lifesciences announces USD 10 mn investment in cGMP Bioconjugation Suite at NJ Bio, Princeton, NJ, U.S. to Accelerate ADC Innovation
  • Biocon Foundation and IISc Commemorate World Head & Neck Cancer Day
  • TPI India Limited secures Rs. 13.77 Crore New Order
  • Infosys Collaborates with Melbourne Archdiocese Catholic Schools to drive Network-Wide Digital Transformation
  • Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™
  • Biocon Biologics receives MHRA UK Approval for Vevzuo® and Evfraxy®, Denosumab Biosimilars
  • ORSL, IIT Bombay, and IIT Kharagpur Join Hands for Breakthrough BioCCU Technology
  • Biocon Biologics expands Insulin Access in Malaysia
  • Confidence Petroleum India Ltd secures bottling assistance contracts from PSUs
  • Biocon Biologics receives Health Canada approval for Yesafili™
  • Biocon Biologics Collaborates with National Cancer Society Malaysia
  • Syngene International Ltd updates on USFDA inspection at Biocon Park, SEZ, Bengaluru
  • Biocon Limited gets approval for diabetes drug Liraglutide in India
  • Shilpa Medicare announces Strategic Partnership with Orion Corporation for Recombinant Human Albumin for European Market
  • Biocon Biologics and Yoshindo expand access to Ustekinumab Biosimilar in Japan
  • Biocon Biologics Secures Strong Market Access Coverage for Yesintek™ in the United States Covering 100+ Million Lives
  • Indian Oil Corporation Limited recommends final dividend of Rs. 3
  • Biocon Biologics Receives Positive CHMP Opinions for Biosimilar Denosumab in Europe
  • Biocon Biologics secures Market Entry Date for Yesafili™, an Interchangeable Biosimilar to Eylea®, in the U.S.

Latest Post

  • Umiya Mobile Limited Strengthens Market Presence with 36 New Stores Post IPO
  • Avantel Ltd to inaugurate new facility on Oct 2, 2025
  • Solarium Green Energy Ltd receives orders worth Rs. 18.77 crores
  • Capricorn Systems Global Solutions Ltd receives order for supply of broken rice
  • Anand Rayons Ltd receives approval for STAPII trademark


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024